Digital Health Startup Funding 2025-2026

What are all the funding deals in the digital health market from June 2025 to May 2026?

The table below lists every disclosed equity round raised by pure-play digital health companies between June 2025 and May 2026. We define the digital health market as products and services that use digital technology to deliver, support, or improve health care and health outcomes.

We include telehealth and virtual care, remote monitoring and connected devices, health IT and clinical workflow software, and patient-facing mobile apps when they are health-focused. For a wider view of how this market is developing, we cover it in our Digital Health market report.

How active has fundraising been in the digital health market?

As of May 2026, fundraising in the digital health market has been active, but not evenly distributed. Over the past 12 months, companies raised 30 disclosed equity rounds and $1.89B combined, which works out to 2.5 deals per month.

The digital health market produced 29 unique funded companies, so the activity was not just a single company raising repeatedly. Still, only OpenEvidence appears twice in the dataset, which makes repeat-company concentration much lower than capital concentration.

Capital raised per month averaged $157.4M, while the median month was $104.6M. That difference matters because several very large rounds in June and July 2025 make the average look stronger than the normal month.

Excluding rounds above $50M reduces total disclosed capital from $1.89B to $374M. That means the digital health market’s funding boom is mostly a scale-up story, not a broad surge in ordinary early-stage financings.

If you’re interested in knowing more about the top startups in this industry, check our market report covering digital health companies.

How concentrated has fundraising been in the digital health market?

As of May 2026, fundraising in the digital health market is highly concentrated around a small number of large rounds. Over the past 12 months, the single largest deal accounts for 15.88% of all capital, the top 3 deals reach 41.98%, and the top 5 reach 61.04%.

The biggest financings are Abridge at $300M, OpenEvidence at $250M, Ambience Healthcare at $243M, OpenEvidence again at $210M, and Aidoc at $150M. Together, they explain most of the market-level dollar narrative.

This concentration changes how the digital health market should be read. A headline about total capital raised is really a headline about a few companies that proved clinical workflow value, clinician usage, or enterprise deployment.

The top 10 deals represent 82.58% of all disclosed capital. Before calling the whole digital health market hot, it is worth asking whether the growth is broad or simply concentrated around a few scaled AI platforms.

How much of the digital health funding signal is driven by outliers?

As of May 2026, a large share of the digital health funding signal is driven by outliers. Over the past 12 months, 9 of 30 deals were above $50M, but those rounds represent $1.515B, or 80.20% of total disclosed capital.

The deal count is not dominated by megarounds, but the dollar total is. Rounds above $50M are only 30.00% of activity, which means most companies still raised smaller venture rounds.

The median round size is $21.75M, while the average is $62.97M. That gap is a simple warning: the average digital health round should not be treated as the typical digital health round.

Rounds above $100M are even more selective. They account for 7 deals, or 23.33% of all deals, but they drive the category narrative because they include Abridge, OpenEvidence, Ambience Healthcare, Hippocratic AI, Tennr, and Aidoc.

For more context on which rounds drove the headline, see our deeper analysis of the digital health market.

Is the digital health market broad with many targets, or narrow with few fundable companies?

As of May 2026, the digital health market is broad at the formation level but narrow at the scale-financing level. Over the past 12 months, the dataset includes 29 unique companies, but most capital pools around a small number of proven platforms.

The 30 deals cover several categories, including clinical workflow software, virtual care platforms, care navigation platforms, patient engagement tools, and health data infrastructure. That shows real breadth across use cases.

But the capital distribution is much narrower than the company count. The top 5 deals capture 61.04% of disclosed dollars, and the top 10 deals capture 82.58%, which means only a minority of companies set the market’s financial tone.

The digital health market is therefore best read as a broad funnel with a narrow scale-up layer. Many companies can raise, but only a few can command late-stage or megaround-sized checks.

Is digital health mostly an early-stage formation market or a late-stage scaling market?

As of May 2026, the digital health market is numerically early-stage but financially late-stage. Over the past 12 months, Seed and Series A rounds represent 63.33% of deals, but they capture only 16.41% of capital.

Series A is the busiest stage in the digital health market, with 15 of 30 deals. Yet those Series A rounds add up to only $276.5M, or 14.64% of disclosed capital.

Later-stage rounds carry the dollar weight. Series B and later, plus Growth Equity, account for $1.579B, or 83.59% of all disclosed capital in the digital health market.

This split suggests investors are still creating new digital health companies, but the biggest checks go to businesses that already show enterprise adoption, health-system proof, or repeatable clinical usage.

If you want to learn more about what investors are currently betting on, check out our report on the digital health market.

Which categories attract the most investor attention in digital health?

As of May 2026, Clinical Workflow Software attracts the most investor attention in digital health. Over the past 12 months, the category accounts for 12 of 30 deals and $942.6M raised.

That gives Clinical Workflow Software 40.00% of deal count and 49.90% of total disclosed capital. It is the only category that leads both by number of rounds and by dollars raised.

The category includes documentation, coding, scheduling, referrals, prior authorization, finance operations, and imaging triage. These are not generic AI products; they target specific clinical or administrative bottlenecks.

Virtual Care Platforms rank second by deal count with 6 deals, while Health Data Infrastructure ranks second by capital with $469.3M. That split shows that investor attention is not one-dimensional: some categories produce many rounds, while others produce fewer but much larger checks.

Which categories attract disproportionately large checks in the digital health market?

As of May 2026, Health Data Infrastructure attracts the most disproportionately large checks in the digital health market. Over the past 12 months, the category captured only 10.00% of deals but 24.84% of capital.

The capital share to deal share ratio for Health Data Infrastructure is 2.48, the highest in the dataset. That is mainly because OpenEvidence raised $210M in July 2025 and $250M in January 2026.

Clinical Workflow Software also over-indexes, with a capital share to deal share ratio of 1.25. This confirms that investors are willing to pay more for digital health products embedded inside provider workflows and operational economics.

Patient Engagement Tools under-index with a ratio of 0.43. The category still gets funded, but the digital health market gives larger checks to infrastructure and workflow software than to standalone engagement products.

Which geographies matter most for fundraising in the digital health market?

As of May 2026, North America matters most for fundraising in the digital health market. Over the past 12 months, North American companies raised 26 of 30 disclosed deals and $1.66B of capital.

That equals 86.67% of deal count and 87.71% of disclosed capital. The region is not only larger by dollars; it is also structurally larger by number of funded companies.

Asia-Pacific appears in 3 deals and $82.2M of disclosed capital. Its average round size is $27.4M, meaning the region is visible but not yet competing with North America on scale.

The Middle East appears through Aidoc’s $150M round. That single financing gives the region 7.94% of capital, but only 3.33% of deal count, so the regional signal is fragile.

If you want to identify the opportunities currently emerging in this market, explore our market pitch on digital health.

Is the digital health opportunity set broad or concentrated in one hub?

As of May 2026, the digital health opportunity set is heavily concentrated in North America. Over the past 12 months, North America holds 87.71% of disclosed capital and 86.67% of disclosed deals.

Asia-Pacific is present but smaller. It contributes 10.00% of deals and 4.35% of capital, with Everlab, Reveal HealthTech, and Heidi Health representing the region in the dataset.

The Middle East is visible only because of Aidoc’s $150M round. One large deal can make a region look meaningful in capital terms even when the underlying company count is thin.

Europe, Latin America, and Africa do not appear in the high-confidence disclosed dataset under the filters used here. That does not mean no digital health activity exists there, but it does mean it did not surface as a dominant public equity-funding signal in this sample.

Is digital health a market of small experiments or scaled financings?

As of May 2026, digital health is a market with many modest rounds and a small set of scaled financings. Over the past 12 months, 14 of 30 deals were between $5M and $20M, while 9 deals were above $50M.

There were no disclosed rounds in the $0.3M to $5M bucket. That likely reflects public-announcement bias, because very small digital health financings are less likely to receive first-hand or tier-1 coverage.

The $50M threshold is the key breakpoint. Rounds above that level are only 30.00% of deals but account for 80.20% of disclosed capital, so scaled financings define the market’s dollar direction.

The median round size is $21.75M, which is much closer to an ordinary venture round than to the biggest megarounds. The average of $62.97M should therefore be read as an outlier-inflated number.

If you want to stay on top of the latest trends, risks, and opportunities in this market, check out our market report on digital health, updated every quarter.

Who are the investors that appear the most in digital health fundraising?

As of May 2026, Andreessen Horowitz and GV are the most visible repeat investors in digital health fundraising. Over the past 12 months, each appears across several of the largest or most strategically important rounds in the dataset.

Andreessen Horowitz appears in Abridge, Ambience Healthcare, Fortuna Health, Counsel Health, and Tennr. That gives it exposure to clinical workflow, care navigation, and AI-enabled healthcare front-door models.

GV appears in OpenEvidence, Counsel Health, Tennr, and Translucent. Its repeat presence suggests a clear preference for healthcare AI tied to clinician knowledge, patient access, and health-system operations.

Kleiner Perkins and Thrive Capital are visible through OpenEvidence and Ambience-type infrastructure or workflow bets. Optum Ventures appears across Reema Health, Ambience Healthcare, and Amigo AI, which points to payer and care-delivery relevance.

One important caveat: round announcements rarely disclose how much each investor personally contributed. The digital health market publishes total round sizes, so investor presence should be read as syndicate participation, not exact dollars committed.

Who is the author of this content?

NEW MARKET PITCH TEAM

We track new markets so founders and investors can move faster

We build living "market pitch" documents for emerging markets: AI, synthetic biology, new proteins, and more. Instead of outdated PDFs or hallucinated LLM answers, our clients get a clean, visual, always-updated view of what's really happening: key players, deals, regulations, and signals that matter. Learn more about us.